Dexcom Q2 FY26 GAAP net income rises 39% to $249.1 million; revenue climbs 13% to $1.31 billion

• DexCom posted Q2 revenue of USD 1.31 billion, up 13% year over year, with U.S. revenue up 11% and international up 19%.
• GAAP operating income climbed to USD 318.3 million, lifting operating margin to 24.3% from 18.4% a year earlier.
• GAAP net income rose to USD 249.1 million, or USD 0.64 per diluted share.
• Non-GAAP operating income increased to USD 328.3 million, taking non-GAAP operating margin to 25.1% from 19.2%.
• Raised 2026 revenue guidance to USD 5.18-5.25 billion; highlighted positive CONNECT trial results and a reimagined Stelo app with AI-driven insights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001093557-26-000142), on July 30, 2026, and is solely responsible for the information contained therein.